Our top pick for
InspireMD, Inc is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NYSE MKT and all prices are listed in US Dollars. InspireMD employs 48 staff and has a trailing 12-month revenue of around USD$3.3 million.
|Latest market close||USD$0.35|
|52-week range||USD$0.28 - USD$1.55|
|50-day moving average||USD$0.3544|
|200-day moving average||USD$0.4521|
|Wall St. target price||USD$0.85|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-9.906|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||-28.57%|
|1 month (2020-12-17)||9.37%|
|3 months (2020-10-15)||9.37%|
|6 months (2020-07-15)||-20.45%|
|1 year (2020-01-15)||-69.83%|
|2 years (2019-01-15)||110.84%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||0.7|
Valuing InspireMD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InspireMD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
InspireMD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, InspireMD shares trade at around 1x recent earnings.
|Revenue TTM||USD$3.3 million|
|Gross profit TTM||USD$756,000|
|Return on assets TTM||-40.25%|
|Return on equity TTM||-96.45%|
|Market capitalisation||USD$13 million|
TTM: trailing 12 months
There are currently 722,671 InspireMD shares held short by investors – that's known as InspireMD's "short interest". This figure is 4.9% up from 689,121 last month.
There are a few different ways that this level of interest in shorting InspireMD shares can be evaluated.
InspireMD's "short interest ratio" (SIR) is the quantity of InspireMD shares currently shorted divided by the average quantity of InspireMD shares traded daily (recently around 1.1 million). InspireMD's SIR currently stands at 0.63. In other words for every 100,000 InspireMD shares traded daily on the market, roughly 630 shares are currently held short.
However InspireMD's short interest can also be evaluated against the total number of InspireMD shares, or, against the total number of tradable InspireMD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InspireMD's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 InspireMD shares in existence, roughly 20 shares are currently held short) or 0.0196% of the tradable shares (for every 100,000 tradable InspireMD shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InspireMD.
Find out more about how you can short InspireMD stock.
We're not expecting InspireMD to pay a dividend over the next 12 months.
InspireMD's shares were split on a 1:50 basis on 1 April 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.
Over the last 12 months, InspireMD's shares have ranged in value from as little as $0.28 up to $1.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while InspireMD's is 2.456. This would suggest that InspireMD's shares are significantly more volatile than the average for this exchange and represent a higher risk.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. is headquartered in Tel Aviv, Israel.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.